Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Randomized, Controlled, Double-blind, Multi-centre, Multinational Study on the Safety and Efficacy of 6% Hydroxyethyl Starch (HES) Solution Versus an Electrolyte Solution in Patients Undergoing Elective Abdominal Surgery

NCT03278548 is registered in ClinicalTrials.gov with Fresenius Kabi as lead sponsor.

NCT NCT03278548
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03278548 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Randomized, Controlled, Double-blind, Multi-centre, Multinational Study on the Safety and Efficacy of 6% Hydroxyethyl Starch (HES) Solution Versus an Electrolyte Solution in Patients Undergoing Elective Abdominal Surgery
Lead sponsor
Fresenius Kabi
Phase
Phase 4
Overall status
Completed
Start date
September 28, 2017
Completion date
July 6, 2022
Enrollment
2,289 (actual)
Sites
61

Conditions

As the registry lists them; a condition with its own page is linked.

hypovolaemia due to acute blood loss